SMT and HeartX Forge Transformative Partnership in Cardiovascular Space

May 03, 2024

Mumbai (Maharashtra) [India], May 3: SMT (Sahajanand Medical Technologies), a renowned medical device company at the forefront of innovative patient care in the cardiovascular...

Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients

Oct 26, 2023

Mumbai (Maharashtra) [India], October 26: SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on innovative patient care in cardiovascular segment,...

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

Nov 01, 2023

Mumbai (Maharashtra) [India], November 1: SMT (Sahajanand Medical Technologies), a renowned medical device company at the forefront of innovative patient care in the cardiovascular...

SMT Won the Italian National CONSIP 2-Year Tender to Supply Hydra TAVI in All Italian Hospitals

Aug 09, 2024

Mumbai (Maharashtra) [India], August 9: SMT (Sahajanand Medical Technologies Ltd.) is proud to announce its classification in the Italian national CONSIP 2-year tender to...

SMT Announces Positive Results of S-Flex UK-II Registry at TCT 2023

Oct 27, 2023

Mumbai (Maharashtra) [India], October 27: SMT (Sahajanand Medical Technologies), a pioneering healthcare company in India with a focus on innovative patient care in the...

SMT Completes Enrollment in Multivessel TALENT Trial for Supraflex Cruz Stent

Oct 03, 2024

Mumbai (Maharashtra) [India], October 3: Sahajanand Medical Technologies (SMT) is excited to announce the successful completion of patient enrollment in the Multivessel TALENT trial,...